{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:17:03Z","timestamp":1784895423295,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11102-016-0767-5","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T04:39:36Z","timestamp":1477370376000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Management of prolactinomas: a survey of physicians from the Middle East and North Africa"],"prefix":"10.1007","volume":"20","author":[{"given":"Salem A.","family":"Beshyah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim H.","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Chentli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Hamrahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly B.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Raef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Fikki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Jambart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"issue":"1","key":"767_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ecl.2014.11.003","volume":"44","author":"A Glezer","year":"2015","unstructured":"Glezer A, Bronstein MD (2015) Prolactinomas. Endocrinol Metab Clin North Am 44(1):71\u201378","journal-title":"Endocrinol Metab Clin North Am"},{"key":"767_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"Klibanski A (2010) Prolactinomas. N Engl J Med 362:1219\u20131226","journal-title":"N Engl J Med"},{"issue":"349","key":"767_CR3","doi-asserted-by":"crossref","first-page":"g5390","DOI":"10.1136\/bmj.g5390","volume":"10","author":"A Rogers","year":"2014","unstructured":"Rogers A, Karavitaki N, Wass JA (2014) Diagnosis and management of prolactinomas and non-functioning pituitary adenomas. BMJ 10(349):g5390","journal-title":"BMJ"},{"key":"767_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al (2006) Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265\u2013273","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"767_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"767_CR6","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"Maiter D, Delgrange E (2014) Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur J Endocrinol 170(6):R213\u2013R227","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"767_CR7","first-page":"316","volume":"41","author":"A Tirosh","year":"2016","unstructured":"Tirosh A, Shimon I (2016) Current approach to treatments for prolactinomas. Minerva Endocrinol 41(3):316\u2013323","journal-title":"Minerva Endocrinol"},{"key":"767_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0217-8","volume":"13","author":"L Vilar","year":"2010","unstructured":"Vilar L, Naves LA, Casulari LA, Azevedo MF, Albuquerque JL, Serfaty FM et al (2010) Management of prolactinomas in Brazil: an electronic survey. Pituitary 13:199\u2013206","journal-title":"Pituitary"},{"issue":"12","key":"767_CR9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4158\/EP15938.DSC","volume":"21","author":"SL Samson","year":"2015","unstructured":"Samson SL, Hamrahian AH, Ezzat S, AACE Neuroendocrine and Pituitary Scientific Committee (2015) American College of Endocrinology (ACE). American Association of Clinical Endocrinologists, American College of Endocrinology disease state clinical review: Clinical relevance of macroprolactin in the absence of or presence of true hyperprolactinaemia. Endocr Pract 21(12):1427\u20131435","journal-title":"Endocr Pract"},{"issue":"1","key":"767_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ando.2014.10.002","volume":"76","author":"T Cuny","year":"2015","unstructured":"Cuny T, Barlier A, Feelders R, Weryha G, Hofland LJ, Ferone D, Gatto F (2015) Medical therapies in pituitary adenomas: current rationale for the use and future perspectives. Ann Endocrinol (Paris) 76(1):43\u201358","journal-title":"Ann Endocrinol (Paris)"},{"issue":"5","key":"767_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","volume":"18","author":"J Hu","year":"2015","unstructured":"Hu J, Zheng X, Zhang W, Yang H (2015) Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis. Pituitary 18(5):745\u2013751","journal-title":"Pituitary"},{"key":"767_CR12","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","volume":"84","author":"J Verhelst","year":"1999","unstructured":"Verhelst J, Abs R, Maiter D, Vandeweghe M, Velkeniers B, Mockel J et al (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84:2518\u20132522","journal-title":"J Clin Endocrinol Metab"},{"key":"767_CR13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 331:904\u2013909","journal-title":"N Engl J Med"},{"issue":"1","key":"767_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ecl.2014.10.007","volume":"44","author":"RS Auriemma","year":"2015","unstructured":"Auriemma RS, Pivonello R, Ferreri L, Priscitelli P, Colao A (2015) Cabergoline use for pituitary tumors and valvular disorders. Endocrinol Metab Clin North Am 44(1):89\u201397","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"767_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"767_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","volume":"14","author":"M Babey","year":"2011","unstructured":"Babey M, Sahli R, Vajtai I, Andres RH, Seiler RW (2011) Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. Pituitary 14(3):222\u2013230","journal-title":"Pituitary"},{"key":"767_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jcem-68-2-412","volume":"68","author":"J Schlechte","year":"1989","unstructured":"Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A (1989) The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68:412\u2013418","journal-title":"J Clin Endocrinol Metab"},{"key":"767_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2005.02293.x","volume":"63","author":"M Biswas","year":"2005","unstructured":"Biswas M, Smith J, Jadon D, McEwan P, Rees DA, Evans LM et al (2005) Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clin Endocrinol (Oxf) 63:26\u201331","journal-title":"Clin Endocrinol (Oxf)"},{"key":"767_CR19","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1210\/jc.2008-2103","volume":"94","author":"J Kharlip","year":"2009","unstructured":"Kharlip J, Salvatori R, Yenokyan G, Wand GS (2009) Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab 94:2428\u20132436","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"767_CR20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12020-014-0377-9","volume":"48","author":"D Iacovazzo","year":"2015","unstructured":"Iacovazzo D, De Marinis L (2015) Treatment of hyperprolactinemia in post-menopausal women: pros. Endocrine 48(1):76\u201378","journal-title":"Endocrine"},{"issue":"1","key":"767_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-014-0308-9","volume":"48","author":"AT Faje","year":"2015","unstructured":"Faje AT, Klibanski A (2015) The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons. Endocrine 48(1):79\u201382","journal-title":"Endocrine"},{"issue":"2","key":"767_CR22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","volume":"77","author":"D Maiter","year":"2016","unstructured":"Maiter D (2016) Prolactinoma and pregnancy: from the wish of conception to lactation. Ann Endocrinol 77(2):128\u2013134","journal-title":"Ann Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0767-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-016-0767-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0767-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:01:25Z","timestamp":1498341685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-016-0767-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1007\/s11102-016-0767-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}